NCT03468556: A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis
- State
- Not started
- Phase
- Phase 2
- People
- 80 planned
- Started
- 1 Apr 2026
- Primary completion
- 30 Apr 2027
- Arms
- test drug
- Results
- None posted
- 16 Mar 2018: Trial registered